COVID-19 vaccine effectiveness against Omicron or Delta symptomatic infection and severe outcomes

A CITF-funded study led by Dr. Jeff Kwong (University of Toronto), published in JAMA Network Open, estimated that two doses of any COVID-19 vaccine were highly effective against a symptomatic Delta infection, but efficacy was lower and protection was more short-lived against a symptomatic Omicron infection.